Literature DB >> 16877639

Tardive dyskinesia circa 2006.

John M Kane.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16877639     DOI: 10.1176/ajp.2006.163.8.1316

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  13 in total

1.  Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors:  Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal:  Neurol Clin       Date:  2011-02       Impact factor: 3.806

2.  Evaluation of an Educational Program for Clinical Pharmacists to Conduct Standardized Assessments for Medication-Induced Movement-Related Disorders.

Authors:  Alessandra Spadaro; Jamie Kellar; Gary Remington; Beth Sproule; Mayce Al-Sukhni; Albert Chaiet
Journal:  Can J Hosp Pharm       Date:  2015 May-Jun

3.  Back to the future: how good are doctors at gazing in the crystal ball?

Authors:  Rob Stepney
Journal:  BMJ       Date:  2006-12-23

4.  Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.

Authors:  Jeroen P Koning; Jelle Vehof; Huibert Burger; Bob Wilffert; Asmar Al Hadithy; Behrooz Alizadeh; Peter N van Harten; Harold Snieder
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

5.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

Review 6.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

7.  Pharmacological interventions for those who have sexually offended or are at risk of offending.

Authors:  Omer Khan; Michael Ferriter; Nick Huband; Nadja Smailagic
Journal:  Cochrane Database Syst Rev       Date:  2009

Review 8.  Pharmacological interventions for those who have sexually offended or are at risk of offending.

Authors:  Omer Khan; Michael Ferriter; Nick Huband; Melanie J Powney; Jane A Dennis; Conor Duggan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

Review 9.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

Review 10.  Individualizing antipsychotic drug therapy in schizophrenia: the promise of pharmacogenetics.

Authors:  Charles U Nnadi; Anil K Malhotra
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.